The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
α‐Synuclein and Parkinson's disease
Abstract
Alpha‐synuclein (α‐syn) is a small soluble protein expressed primarily at presynaptic terminals in the central nervous system. Interest in α‐syn has increased dramatically after the discovery of a relationship between its dysfunction and several neurodegenerative diseases, including Parkinson's disease (PD). The physiological functions of α‐syn remain to be fully defined, although recent data suggest a role in regulating membrane stability and neuronal plasticity. Various trigger factors, either environmental or genetic, can lead to a cascade of events involving misfolding or loss of normal function of α‐syn. In dopaminergic neurons, this may promote a vicious cycle in which elevation in cytoplasmic dopamine, oxidative stress, α‐syn dysfunction, and disruption of vesicle function lead to dopaminergic cell loss and PD. α‐Syn dysfunction appears to be a common feature of all forms of PD. The mechanism by which α‐syn induces neuronal cell toxicity may invoke multiple pathways, such as aggregation or interaction with other proteins and molecules, including synphilin‐1, chaperone 14‐3‐3 protein, and dopamine itself. This complexity has hindered the development of models to study PD. The available animal models of PD, each present distinct advantages and limits. Findings to date suggest that α‐syn‐based models represent a paradigm, which is closest to the human pathology.— Recchia, A., Debetto, P., Negro, A., Guidolin, D., Skaper, S. D., Giusti, P. α‐Synuclein and Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Apoptosis in the nervous system
Yuan, J., & Yankner, B. A. (2000) · Nature · doi:10.1038/35037739 · Cited by 1,877
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,641
The 26S Proteasome: A Molecular Machine Designed for Controlled Proteolysis
Voges, D., Zwickl, P., & Baumeister, W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.1015 · Cited by 1,608
Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes
Davidson, W. S., Jonas, A., Clayton, D. F., & George, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9443 · Cited by 1,585
14-3-3 Proteins: Structure, Function, and Regulation
Fu, H., Subramanian, R. R., & Masters, S. C. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.617 · Cited by 1,579
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Conway, K. A., Lee, S.-J., Rochet, J.-C., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,541
Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,499
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,480
Neuropathology of Parkinsonʼs Disease
Forno, L. S. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,465
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316
Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein
Lotharius, J., & Brundin, P. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn983 · Cited by 1,283
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Eliezer, D., Kutluay, E., Bussell, R., & Browne, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4538 · Cited by 1,090
Giasson, B. I., Murray, I. V. J., Trojanowski, J. Q., & Lee, V. M.-Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008919200 · Cited by 1,080
Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S., & Selkoe, D. J. (2001) · Science · doi:10.1126/science.1060627 · Cited by 1,053
George, J. M., Jin, H., Woods, W. S., & Clayton, D. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90040-3 · Cited by 844
Murphy, D. D., Rueter, S. M., Trojanowski, J. Q., & Lee, V. M.-Y. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03214.2000 · Cited by 836
Conway, K. A., Harper, J. D., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi991447r · Cited by 786
Xu, J., Kao, S.-Y., Lee, F. J. S., Song, W., Jin, L.-W., & Yankner, B. A. (2002) · Nature Medicine · doi:10.1038/nm0602-600 · Cited by 757
Chung, K. K. K., Zhang, Y., Lim, K. L., Tanaka, Y., Huang, H., Gao, J., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2001) · Nature Medicine · doi:10.1038/nm1001-1144 · Cited by 750
Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation
Serpell, L. C., Berriman, J., Jakes, R., Goedert, M., & Crowther, R. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4897 · Cited by 748
α-Synuclein Fibrillogenesis Is Nucleation-dependent
Wood, S. J., Wypych, J., Steavenson, S., Louis, J.-C., Citron, M., & Biere, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19509 · Cited by 720
Understanding cell death in parkinson's disease
Jenner, P., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440712 · Cited by 685
Kirik, D., Rosenblad, C., Burger, C., Lundberg, C., Johansen, T. E., Muzyczka, N., Mandel, R. J., & Björklund, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02780.2002 · Cited by 649
Kahle, P. J., Neumann, M., Ozmen, L., Müller, V., Jacobsen, H., Schindzielorz, A., Okochi, M., Leimer, U., van der Putten, H., Probst, A., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06365.2000 · Cited by 641
Experimental models of Parkinson's disease
Beal, M. F. (2001) · Nature Reviews Neuroscience · doi:10.1038/35072550 · Cited by 637
A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis
Perez, R. G., Waymire, J. C., Lin, E., Liu, J. J., Guo, F., & Zigmond, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03090.2002 · Cited by 598
Animal models of Parkinson's disease
Betarbet, R., Sherer, T. B., & Greenamyre, J. T. (2002) · BioEssays · doi:10.1002/bies.10067 · Cited by 592
Altered proteasomal function in sporadic Parkinson’s disease
St. P. McNaught, K., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8050 · Cited by 573
α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins
Ostrerova, N., Petrucelli, L., Farrer, M., Mehta, N., Choi, P., Hardy, J., & Wolozin, B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05782.1999 · Cited by 564
Dityrosine Cross-linking Promotes Formation of Stable α-Synuclein Polymers
Souza, J. M., Giasson, B. I., Chen, Q., Lee, V. M.-Y., & Ischiropoulos, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000206200 · Cited by 563
A Broken α-Helix in Folded α-Synuclein
Chandra, S., Chen, X., Rizo, J., Jahn, R., & Südhof, T. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213128200 · Cited by 540
Constitutive Phosphorylation of the Parkinson's Disease Associated α-Synuclein
Okochi, M., Walter, J., Koyama, A., Nakajo, S., Baba, M., Iwatsubo, T., Meijer, L., Kahle, P. J., & Haass, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.390 · Cited by 519
Li, J., Uversky, V. N., & Fink, A. L. (2001) · Biochemistry · doi:10.1021/bi010616g · Cited by 513
Physiology and Anatomy of Possible Oscillators in the Central Nervous System
Rothwell, J. C. (2008) · Movement Disorders · doi:10.1002/mds.870131304 · Cited by 511
Volles, M. J., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi0121353 · Cited by 487
Zigmond, R. E., Schwarzschild, M. A., & Rittenhouse, A. R. (1989) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.12.030189.002215 · Cited by 484
Lo Bianco, C., Ridet, J.-L., Schneider, B. L., Déglon, N., & Aebischer, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152339799 · Cited by 482
Suh, Y.-H., & Checler, F. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.469 · Cited by 467
The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity
Ostrerova-Golts, N., Petrucelli, L., Hardy, J., Lee, J. M., Farer, M., & Wolozin, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06048.2000 · Cited by 466
Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson’s disease?
Goldberg, M. S., & Lansbury Jr, P. T. (2000) · Nature Cell Biology · doi:10.1038/35017124 · Cited by 458
Lee, H.-J., Choi, C., & Lee, S.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107045200 · Cited by 450
Synucleins in synaptic plasticity and neurodegenerative disorders
Clayton, D. F., & George, J. M. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991001)58:1<120::aid-jnr12>3.0.co;2-e · Cited by 442
Jenco, J. M., Rawlingson, A., Daniels, B., & Morris, A. J. (1998) · Biochemistry · doi:10.1021/bi972776r · Cited by 431
Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro
Hashimoto, M., Hsu, L. J., Xia, Y., Takeda, A., Sisk, A., Sundsmo, M., & Masliah, E. (1999) · NeuroReport · doi:10.1097/00001756-199903170-00011 · Cited by 429
Galvin, J. E., Uryu, K., Lee, V. M.-Y., & Trojanowski, J. Q. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13450 · Cited by 422
Synthetic filaments assembled from C‐terminally truncated α‐synuclein
Crowther, R. A., Jakes, R., Spillantini, M. G., & Goedert, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01146-6 · Cited by 417
Genetic and environmental factors in the cause of Parkinson's disease
Warner, T. T., & Schapira, A. H. V. (2003) · Annals of Neurology · doi:10.1002/ana.10487 · Cited by 399
Synucleins Are a Novel Class of Substrates for G Protein-coupled Receptor Kinases
Pronin, A. N., Morris, A. J., Surguchov, A., & Benovic, J. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003542200 · Cited by 387
Brain iron pathways and their relevance to Parkinson's disease
Berg, D., Gerlach, M., Youdim, M. B. H., Double, K. L., Zecca, L., Riederer, P., & Becker, G. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00608.x · Cited by 362
Lavedan, C. (1998) · Genome Research · doi:10.1101/gr.8.9.871 · Cited by 320
Widespread Alterations of α-Synuclein in Multiple System Atrophy
Dickson, D. W., Liu, W.-K., Hardy, J., Farrer, M., Mehta, N., Uitti, R., Mark, M., Zimmerman, T., Golbe, L., Sage, J., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65226-1 · Cited by 306
Formation and Removal of α-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors
Lee, H.-J., Shin, S. Y., Choi, C., Lee, Y. H., & Lee, S.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105326200 · Cited by 291
Proteasome inhibition causes nigral degeneration with inclusion bodies in rats
McNaught, K. S. P., Bj??rklund, L. M., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2002) · Neuroreport · doi:10.1097/00001756-200208070-00018 · Cited by 274
Phospholipase D Stimulates Release of Nascent Secretory Vesicles from the trans-Golgi Network
Chen, Y.-G., Siddhanta, A., Austin, C. D., Hammond, S. M., Sung, T.-C., Frohman, M. A., Morris, A. J., & Shields, D. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.3.495 · Cited by 255
Rare genetic mutations shed light on the pathogenesis of Parkinson disease
Dawson, T. M., & Dawson, V. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17575 · Cited by 238
(2002) · doi:10.1016/s0304-3940(02)00016-2 · Cited by 225
Rochet, J.-C., Conway, K. A., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi001315u · Cited by 222
Clinical and quantitative pathologic correlates of dementia with Lewy bodies
Gómez-Tortosa, E., Newell, K., Irizarry, M. C., Albert, M., Growdon, J. H., & Hyman, B. T. (1999) · Neurology · doi:10.1212/wnl.53.6.1284 · Cited by 204
Complex relationship between Parkin mutations and Parkinson disease
West, A., Periquet, M., Lincoln, S., Lücking, C. B., Nicholl, D., Bonifati, V., Rawal, N., Gasser, T., Lohmann, E., Deleuze, J., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10525 · Cited by 203
Boston, P. F., Jackson, P., & Thompson, R. J. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb07928.x · Cited by 190
Iwatsubo, T., Yamaguchi, H., Fujimuro, M., Yokosawa, H., Ihara, Y., Trojanowski, J. Q., & Lee, V. M. (1996) · Europe PMC (PubMed Central) · Cited by 179
Biere, A. L., Wood, S. J., Wypych, J., Steavenson, S., Jiang, Y., Anafi, D., Jacobsen, F. W., Jarosinski, M. A., Wu, G.-M., Louis, J.-C., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005514200 · Cited by 178
Taki, J., Nakajima, K., Hwang, E.-H., Matsunari, I., Komai, K., Yoshita, M., Sakajiri, K., & Tonami, N. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050544 · Cited by 176
Siderowf, A., & Stern, M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-8-200304150-00013 · Cited by 164
Structural and Functional Implications of C-Terminal Regions of α-Synuclein
Kim, T. D., Paik, S. R., & Yang, C.-H. (2002) · Biochemistry · doi:10.1021/bi026284c · Cited by 162
α-Synuclein Is Phosphorylated by Members of the Src Family of Protein-tyrosine Kinases
Ellis, C. E., Schwartzberg, P. L., Grider, T. L., Fink, D. W., & Nussbaum, R. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010316200 · Cited by 161
Jones, D. C., Gunasekar, P. G., Borowitz, J. L., & Isom, G. E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742296.x · Cited by 157
Baptista, M. J., O’Farrell, C., Daya, S., Ahmad, R., Miller, D. W., Hardy, J., Farrer, M. J., & Cookson, M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01742.x · Cited by 154
Dawson, T. M., Mandir, A. S., & Lee, M. K. (2002) · Neuron · doi:10.1016/s0896-6273(02)00780-8 · Cited by 154
Aggregation and neurotoxicity of α-synuclein and related peptides
EI-Agnaf, O. M. A., & Irvine, G. B. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300559 · Cited by 151
De, D., & McDermott, J. L. (2000) · PubMed · Cited by 139
Activated Fyn Phosphorylates α-Synuclein at Tyrosine Residue 125
Nakamura, T., Yamashita, H., Takahashi, T., & Nakamura, S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4253 · Cited by 138
McKeith, I. G., Burn, D. J., Ballard, C. G., Collerton, D., Jaros, E., Morris, C. M., McLaren, A., Perry, E. K., Perry, R., Piggott, M. A., et al. (2003) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2003.50006 · Cited by 135
Multiple system atrophy: cellular and molecular pathology
Burn, D. J., & Jaros, E. (2001) · Molecular Pathology · doi:10.1136/mp.54.6.419 · Cited by 130
Newell, K. L., Boyer, P., Gomez-Tortosa, E., Hobbs, W., Hedley-Whyte, E. T., Vonsattel, J. P., & Hyman, B. T. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199912000-00007 · Cited by 128
Park, S. M., Jung, H. Y., Kim, T. D., Park, J. H., Yang, C., & Kim, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111971200 · Cited by 126
Tau and α-Synuclein Pathology in Amygdala of Parkinsonism-Dementia Complex Patients of Guam
Forman, M. S., Schmidt, M. L., Kasturi, S. S., Perl, D. P., Lee, V. M. ‐., & Trojanowski, J. Q. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61119-4 · Cited by 125
Negro, A., Brunati, A. M., Donella‐Deana, A., Massimino, M. L., & Pinna, L. A. (2001) · The FASEB Journal · doi:10.1096/fj.01-0517fje · Cited by 121
Self-citationUnfolding the role of chaperones and chaperonins in human disease
Slavotinek, A. M., & Biesecker, L. G. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02413-1 · Cited by 119
Rabinovic, A. D., Lewis, D. A., & Hastings, T. G. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00293-1 · Cited by 117
Increased dopamine turnover after partial loss of dopaminergic neurons: compensation or toxicity?
Zigmond, M. J., Hastings, T. G., & Perez, R. G. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(02)00019-6 · Cited by 113
Assignment of Human α-Synuclein (SNCA) and β-Synuclein (SNCB) Genes to Chromosomes 4q21 and 5q35
Spillantini, M. G., Divane, A., & Goedert, M. (1995) · Genomics · doi:10.1006/geno.1995.1063 · Cited by 109
Pure autonomic failure in association with human α-synucleinopathy
Arai, K., Kato, N., Kashiwado, K., & Hattori, T. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01623-2 · Cited by 108
Amino acid determinants of α‐synuclein aggregation: putting together pieces of the puzzle
Uversky, V. N., & Fink, A. L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02883-1 · Cited by 105
Nakajo, S., Shioda, S., Nakai, Y., & Nakaya, K. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90187-2 · Cited by 100
Tyrosine 125 of α-synuclein plays a critical role for dimerization following nitrative stress
Takahashi, T., Yamashita, H., Nakamura, T., Nagano, Y., & Nakamura, S. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02498-8 · Cited by 97
Spillantini, M. G., Tolnay, M., Love, S., & Goedert, M. (1999) · Acta Neuropathologica · doi:10.1007/s004010051034 · Cited by 80
Kahle, P. J., Haass, C., Kretzschmar, H. A., & Neumann, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01020.x · Cited by 76
Autonomic Failure, Depression and Anxiety in Parkinson's Disease
Berríos, G. E., Campbell, C., & Polityńska, B. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.166.6.789 · Cited by 70
Saito, Y., Kawai, M., Inoue, K., Sasaki, R., Arai, H., Nanba, E., Kuzuhara, S., Ihara, Y., Kanazawa, I., & Murayama, S. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00337-3 · Cited by 68
Genetics of Parkinson's Disease
Polymeropoulos, M. H. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06901.x · Cited by 64
Rajagopalan, S., & Andersen, J. K. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00283-4 · Cited by 56
Association of Lewy bodies and glial cytoplasmic inclusions in the brain of Parkinson's disease
Mochizuki, A., Komatsuzaki, Y., & Shoji, S. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0582-0 · Cited by 33
McLean, P. J., & Hyman, B. T. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00154-4 · Cited by 32
Linking ubiquitin, parkin and synphilin-1
Ciechanover, A. J. (2001) · Nature Medicine · doi:10.1038/nm1001-1108 · Cited by 30
Dementia with Lewy bodies in Down's syndrome
Simard, M., & van Reekum, R. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.342 · Cited by 20
Advances in genetic models of Parkinson's disease
Lee, M. K., & Price, D. L. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00024-x · Cited by 8
Cited by
Devi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G., & Anandatheerthavarada, H. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710012200 · Cited by 1,080
The fold of α-synuclein fibrils
Vilar, M., Chou, H.-T., Lührs, T., Maji, S. K., Riek-Loher, D., Verel, R., Manning, G., Stahlberg, H., & Riek, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712179105 · Cited by 541
α-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesis
Mehra, S., Sahay, S., & Maji, S. K. (2019) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2019.03.001 · Cited by 499
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron
Skaper, S. D., Facci, L., Zusso, M., & Giusti, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00072 · Cited by 457
Self-citationUversky, V. N. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0937-z · Cited by 312
Metadata
- Authors
- Recchia, A., Debetto, P., Negro, A., Guidolin, D., Skaper, S. D., & Giusti, P.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-04
- Volume
- 18
- Issue
- 6
- Pages
- 617-626
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2114200547
- Cited by
- 318
- References
- 110
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.